• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Relay Robotics Secures $10 Million Financing

    5/2/22 7:00:00 AM ET
    $CSCO
    $CTXS
    $GDRX
    Computer Communications Equipment
    Telecommunications
    Computer Software: Prepackaged Software
    Technology
    Get the next $CSCO alert in real time by email

    Acquires Savioke R&D, Relay® Product Line

    Names Michael O'Donnell Chairman & CEO

    Relay Robotics, Inc. — a new corporation formed by the acquisition of leading robotics developer Savioke — announced the completion of a $10,000,000 Series A Financing and the appointment of veteran technology executive, Michael O'Donnell, as Chairman and Chief Executive Officer. Savioke Co-Founder, Steve Cousins, will become Chief Technology Officer of Relay Robotics and lead the company's product strategy and innovation efforts.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220501005046/en/

    Michael O'Donnell, Chairman and Chief Executive Officer, Relay Robotics, Inc. (Photo: Business Wire)

    Michael O'Donnell, Chairman and Chief Executive Officer, Relay Robotics, Inc. (Photo: Business Wire)

    Relay delivery robots are currently deployed at major hotels in the United States such as Marriott, Hilton, Westin, Mandarin Oriental, Holiday Inn, and Radisson, nationally recognized hospitals such as Georgetown and Dartmouth, and commercial real estate properties. Relay's Rapid-Install™ trains and activates a robot within hours of arrival at a location. Customers can name their robot and create a customized "wrap" to give it a unique character and harmonize it with their brand.

    "Our ownership's crystal ball saw, before most hotel operators, what service robot technology could add from a marketing and operations perspective," says Bob Combie, Senior Vice President of Technology at Seaview Investors, a leading hotel operator. "The Relay robots are integrated into our daily guest experience, and we use them at all eight of our hotels."

    The Relay product line consists of:

    • Relay® – The original service robot, globally installed in hotels, hospitals, and commercial real estate.
    • Relay+® – The newest autonomous robot with flexible configurations including a larger capacity top bin, a 4-drawer model, and independent elevator operations.

    With COVID-19 retreating, the markets Relay Robotics serves (hospitality, healthcare, and real estate), are poised for a robust recovery. The global hospitality market is expected to grow from $3.9 trillion in 2021 to $4.5 trillion in 2022 at a compound annual growth rate (CAGR) of 15.1% and is expected to reach $6.7 trillion in 2026 at a CAGR of 10.2%1.

    "I'm excited to join Steve and the incredibly talented team at Relay Robotics to address this huge market opportunity for autonomous robots that help businesses serve their customers, patients, and employees," said Michael O'Donnell. "The market is quickly embracing these AI & autonomous technologies to address the worldwide labor shortage and meet their clients' needs. Relay Robotics has the intellectual property, a product line of working robots making deliveries across hospitality, healthcare and offices, and a pipeline of marquee customers."

    "There is a multibillion-dollar market for service robots and Relay Robotics has the team, technology and real-world experience in applying service robots to solve business problems," noted Mark Koulogeorge, Managing Partner at MK Capital which led the Series A Financing. "Michael will lead Relay on an aggressive growth path as we partner with customers to develop more innovative uses of service robots to enhance the customer experience and improve operating efficiency."

    "Our collective experience and expertise in AI, autonomous vehicles, and building the Relay software technology platform is paying huge dividends in driving use cases and the reliability of our robots," said Steve Cousins, Chief Technology Officer. "We continue to expand the capabilities of Relay robots, enabling them to be quickly deployed to help people in service industries."

    O'Donnell, a 25-year veteran of the consumer technology industry, brings a track record of growth and success at early-stage technology companies. Prior to Relay Robotics, he was CEO of HealthiNation, a digital healthcare media company that he and his team grew over 280% and was acquired by GoodRx (NASDAQ:GDRX) in April 2021. Before HealthiNation, O'Donnell was CEO of four successful VC-backed technology companies, including Playcast, an Israel-based videogame streaming company acquired by GameFly, Inc. in 2015; Skytide, a video analytics company acquired by Citrix Systems, Inc. (NASDAQ:CTXS) in 2013; Five Across, a social media platform company acquired by Cisco Systems, Inc. (NASDAQ:CSCO) in 2007; and Salon Media Group (NASDAQ IPO, 2001).

    About Relay Robotics

    Relay Robotics, Inc. is a leading supplier of simple, sophisticated, autonomous service robots that work with humans safely, securely, reliably, and contact-free. Relay Robotics and its affiliates have been technology leaders in robotics since 2013 and hold 10 U.S. patents. Relay's robots supplement staff across hospitality, healthcare, and commercial real estate settings. They have completed more than 1,000,000 deliveries worldwide.

    For more information about Relay Robotics, Inc., visit www.relayrobotics.com.

    1. The Hospitality Global Market Report 2022, December 2021, The Business Research Company

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220501005046/en/

    Get the next $CSCO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CSCO
    $CTXS
    $GDRX

    CompanyDatePrice TargetRatingAnalyst
    Cisco Systems Inc.
    $CSCO
    8/15/2025$69.00Buy → Hold
    HSBC Securities
    GoodRx Holdings Inc.
    $GDRX
    8/11/2025Strong Buy → Outperform
    Raymond James
    Cisco Systems Inc.
    $CSCO
    7/28/2025$72.00Outperform → In-line
    Evercore ISI
    Cisco Systems Inc.
    $CSCO
    7/8/2025Peer Perform
    Wolfe Research
    Cisco Systems Inc.
    $CSCO
    6/26/2025$77.00Overweight
    KeyBanc Capital Markets
    Cisco Systems Inc.
    $CSCO
    6/16/2025$73.00Hold → Buy
    Deutsche Bank
    Cisco Systems Inc.
    $CSCO
    5/16/2025$70.00Buy → Neutral
    New Street
    Cisco Systems Inc.
    $CSCO
    5/15/2025$75.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $CSCO
    $CTXS
    $GDRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month

    Until today, Ozempic® has not been available to eligible self-paying patients at this price GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced that via a collaboration with Novo Nordisk, all strengths of Ozempic® (semaglutide) and Wegovy® (semaglutide) pens are available to eligible self-paying patients for $499-per-month through GoodRx, effective today. This collaboration significantly lowers the price available on GoodRx for two of the most in-demand GLP-1 medications nationwide, expanding access for those who lack adequate insurance coverage. Today also marks the first time Ozempic® has been made available to patients at this self-pay price.

    8/18/25 9:05:00 AM ET
    $GDRX
    EDP Services
    Technology

    CISCO REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 EARNINGS

    SAN JOSE, Calif., Aug. 13, 2025 /PRNewswire/ --  News Summary: Strong topline performance at the high end of our guidance ranges:Q4 revenue of $14.7 billion, up 8% year over yearFY 2025 revenue of $56.7 billion, up 5% year over yearQ4 product orders up 7% year over year with growth across all geographies, demonstrating robust demand for Cisco's technologiesAI Infrastructure orders taken from webscale customers exceeded $800 million, bringing the FY 2025 total to over $2 billion, more than double the original $1 billion targetStrong profitability in Q4:GAAP gross margin of 65.

    8/13/25 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    GoodRx Reports Second Quarter 2025 Results

    Second Quarter 2025 Revenue and Adjusted EBITDA Margin in Line with Previous Guidance; Pharma Manufacturer Solutions Revenue Increased 32% Year-Over-Year GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second Quarter 2025 Highlights Revenue of $203.1 million Net income of $12.8 million; Net income margin of 6.3% Adjusted Net Income1 of $33.9 million; Adjusted Net Income Margin1 of 16.7% Adjusted EBITDA1 of $69.4 million; Adjusted EBITDA Margin1 of 34.2% Net cash provided by operating activities of $49.6 million

    8/6/25 4:05:00 PM ET
    $GDRX
    EDP Services
    Technology

    $CSCO
    $CTXS
    $GDRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cisco downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Cisco from Buy to Hold and set a new price target of $69.00

    8/15/25 8:16:28 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    GoodRx downgraded by Raymond James

    Raymond James downgraded GoodRx from Strong Buy to Outperform

    8/11/25 9:45:40 AM ET
    $GDRX
    EDP Services
    Technology

    Cisco downgraded by Evercore ISI with a new price target

    Evercore ISI downgraded Cisco from Outperform to In-line and set a new price target of $72.00

    7/28/25 8:33:52 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $CTXS
    $GDRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CPO Patel Jeetendra I sold $603,437 worth of shares (9,061 units at $66.60), decreasing direct ownership by 4% to 237,405 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    8/19/25 7:02:29 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    Chair and CEO Robbins Charles sold $2,036,057 worth of shares (30,557 units at $66.63), decreasing direct ownership by 5% to 639,000 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    8/19/25 7:01:11 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    EVP and Chief Legal Officer Stahlkopf Deborah L sold $651,568 worth of shares (9,783 units at $66.60), decreasing direct ownership by 6% to 161,662 units (SEC Form 4)

    4 - CISCO SYSTEMS, INC. (0000858877) (Issuer)

    8/19/25 6:59:29 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $CTXS
    $GDRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Wagner Scott bought $124,806 worth of shares (21,652 units at $5.76) (SEC Form 4)

    4 - GoodRx Holdings, Inc. (0001809519) (Issuer)

    12/4/23 4:35:10 PM ET
    $GDRX
    EDP Services
    Technology

    Wagner Scott bought $180,423 worth of shares (30,505 units at $5.91) (SEC Form 4)

    4 - GoodRx Holdings, Inc. (0001809519) (Issuer)

    11/30/23 4:41:35 PM ET
    $GDRX
    EDP Services
    Technology

    Wagner Scott bought $677,475 worth of shares (130,743 units at $5.18) (SEC Form 4)

    4 - GoodRx Holdings, Inc. (0001809519) (Issuer)

    11/17/23 7:08:30 PM ET
    $GDRX
    EDP Services
    Technology

    $CSCO
    $CTXS
    $GDRX
    SEC Filings

    View All

    SEC Form 144 filed by Cisco Systems Inc.

    144 - CISCO SYSTEMS, INC. (0000858877) (Subject)

    8/15/25 4:28:17 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    SEC Form 144 filed by Cisco Systems Inc.

    144 - CISCO SYSTEMS, INC. (0000858877) (Subject)

    8/15/25 4:27:17 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    SEC Form 8-K filed by Cisco Systems Inc.

    8-K - CISCO SYSTEMS, INC. (0000858877) (Filer)

    8/13/25 4:11:01 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $CTXS
    $GDRX
    Financials

    Live finance-specific insights

    View All

    CISCO REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 EARNINGS

    SAN JOSE, Calif., Aug. 13, 2025 /PRNewswire/ --  News Summary: Strong topline performance at the high end of our guidance ranges:Q4 revenue of $14.7 billion, up 8% year over yearFY 2025 revenue of $56.7 billion, up 5% year over yearQ4 product orders up 7% year over year with growth across all geographies, demonstrating robust demand for Cisco's technologiesAI Infrastructure orders taken from webscale customers exceeded $800 million, bringing the FY 2025 total to over $2 billion, more than double the original $1 billion targetStrong profitability in Q4:GAAP gross margin of 65.

    8/13/25 4:05:00 PM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    GoodRx Reports Second Quarter 2025 Results

    Second Quarter 2025 Revenue and Adjusted EBITDA Margin in Line with Previous Guidance; Pharma Manufacturer Solutions Revenue Increased 32% Year-Over-Year GoodRx Holdings, Inc. (NASDAQ:GDRX) ("we," "us," "our," "GoodRx," or the "Company"), the leading platform for medication savings in the U.S., has released its financial results for the second quarter of 2025. Second Quarter 2025 Highlights Revenue of $203.1 million Net income of $12.8 million; Net income margin of 6.3% Adjusted Net Income1 of $33.9 million; Adjusted Net Income Margin1 of 16.7% Adjusted EBITDA1 of $69.4 million; Adjusted EBITDA Margin1 of 34.2% Net cash provided by operating activities of $49.6 million

    8/6/25 4:05:00 PM ET
    $GDRX
    EDP Services
    Technology

    Cisco Schedules Conference Call for Q4 Fiscal Year 2025 Financial Results

    SAN JOSE, Calif., Aug. 4, 2025 /PRNewswire/ -- Cisco (NASDAQ:CSCO) has scheduled a conference call for Wednesday, Aug 13, 2025, at 1:30 PM (PT); 4:30 PM (ET) to announce its fourth quarter fiscal year 2025 financial results for the period ending Saturday, July 26, 2025. Financial results will be released over PR Newswire via US National and European Financial distribution, after the close of the market on Wednesday, Aug 13, 2025. Cisco's quarterly earnings press release will be posted at https://newsroom.cisco.com.   Date:                     Wednesday, Aug 13, 2025 Time:     

    8/4/25 8:00:00 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $CTXS
    $GDRX
    Leadership Updates

    Live Leadership Updates

    View All

    GoodRx Appoints Amazon Pharmacy Veteran Laura Jensen as President of Pharma Solutions

    Seasoned industry leader tapped to help pharma reimagine their go-to-market strategies and direct-to-patient models GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced the appointment of Laura Jensen as Chief Commercial Officer and President of Pharma Solutions, effective July 28, 2025. In this role, Laura will lead the company's Pharma Manufacturer Solutions offering and oversee strategic initiatives aimed at growing and enhancing innovative partnerships across the pharmaceutical industry. Her deep cross-sector experience uniquely positions her to help revolutionize how patients access and afford their medications through the GoodRx platform. T

    7/28/25 9:00:00 AM ET
    $GDRX
    EDP Services
    Technology

    GoodRx Open Sources Lifecycle to Support Innovation in Software Development Velocity and Developer Productivity

    Public release of Lifecycle reflects company's commitment to transparency, innovation, and community collaboration GoodRx (NASDAQ:GDRX), the leading platform for medication savings in the U.S., today announced it is open-sourcing Lifecycle, a homegrown development tool designed to improve team velocity, streamline review workflows, and reduce infrastructure overhead. Lifecycle is now available to the public under the Apache 2.0 license, inviting developers and organizations to adopt, contribute to, and build upon the platform. The tool allows engineering, quality assurance, and platform teams to automatically spin up short-lived, isolated environments—known as ephemeral environments—for

    6/5/25 9:00:00 AM ET
    $GDRX
    EDP Services
    Technology

    Cisco Joins Stargate UAE Initiative

    Cisco to collaborate with G42, OpenAI, Oracle, NVIDI, and SoftBank Group to power AI innovation and infrastructure development in recently announced UAE-US AI Campus in Abu Dhabi News Summary Cisco to provide networking, security and observability hardware and software solutions for OpenAI workloads, advancing AI infrastructure in the Middle East. Strategic partnership supports the Stargate Project's commitment to safe, broadly distributed AI development and responsible capital stewardship.MOU signed by Cisco's Chair and Chief Executive Officer, Chuck Robbins, together with G42, OpenAI, Oracle, NVIDIA and SoftBank Group.MOU aligns with President Trump's visit to the region last week and comp

    5/22/25 11:26:00 AM ET
    $CSCO
    Computer Communications Equipment
    Telecommunications

    $CSCO
    $CTXS
    $GDRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by GoodRx Holdings Inc.

    SC 13G/A - GoodRx Holdings, Inc. (0001809519) (Subject)

    11/14/24 12:29:56 PM ET
    $GDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by GoodRx Holdings Inc.

    SC 13G/A - GoodRx Holdings, Inc. (0001809519) (Subject)

    11/13/24 4:30:24 PM ET
    $GDRX
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by GoodRx Holdings Inc.

    SC 13G/A - GoodRx Holdings, Inc. (0001809519) (Subject)

    11/12/24 4:02:41 PM ET
    $GDRX
    EDP Services
    Technology